5-Amino-1MQ
No completed human trials extracted for 5-Amino-1MQ. Animal-model evidence carries the indication cards below.
Research Evidence
Evidence shape
No completed human trials extracted for 5-Amino-1MQ. Animal-model evidence carries the indication cards below.
Anecdotal efficacy
Side effects
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Price
price offers can be sorted by column
Dosing & Protocol
How 5-Amino-1MQ is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
- Frequency
- BID
- Timing
- unspecified
- Route
- subQ
- Cycle
- unspecified
Clinician protocols dose 50 mg BID subQ (2 sources).
- Frequency
- unspecified
- Timing
- unspecified
- Route
- Unknown
- Cycle
- unspecified
Community reports show some interest in 5-Amino-1MQ for fat loss and body composition, with 66.7% of 15 reports indicating positive outcomes, 13.3% mixed, and 20% negative. Specific dosing details are not widely shared within these anecdotal reports.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Peptide feedback
0 forum repliesLive community discussion for 5-Amino-1MQ, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.